Concepedia

Ignatius Thomas

IT

9

Publications

2.7K

Citations

9

H-Index

1997

Active since

Affiliations

Biogen (United States)(Current)

Southern Arizona VA Health Care System

University of Colorado Denver

Bristol-Myers Squibb (United States)

Tufts Medical Center

Ignatius Thomas is an author at Biogen (United States) specializing in cardiovascular disease, cardiology, and medicine.

Top concepts

Publications per year

1997–2011

9

Publications

9

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

Bertram Pitt, Robert Segal, Felipe A Martinez et al. · The Lancet · 1997 · 1.7K citations

, , +10

BG9719 (CVT-124), an A <sub>1</sub> Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy

Stephen S. Gottlieb, D. Craig Brater, Ignatius Thomas et al. · Circulation · 2002 · 370 citations

Acute Hemodynamic Effects of Conivaptan, a Dual V <sub>1A</sub> and V <sub>2</sub> Vasopressin Receptor Antagonist, in Patients With Advanced Heart Failure

James E. Udelson, William Smith, G Hendrix et al. · Circulation · 2001 · 361 citations · Full text

A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Tolvaptan Monotherapy Compared to Furosemide and the Combination of Tolvaptan and Furosemide in Patients With Heart Failure and Systolic Dysfunction

James E. Udelson, Martin Bilsker, Paul J. Hauptman et al. · Journal of Cardiac Failure · 2011 · 97 citations

, , +7

Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure

Edward P. Havranek, Ignatius Thomas, William Smith et al. · Journal of the American College of Cardiology · 1999 · 66 citations

, , +7

Rows per page

1–5 of 9